As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 3/12/21  Revance Therapeutics, Inc.        PRE 14A    12/31/20    1:8.7M                                                            
 3/11/21  Revance Therapeutics, Inc.        DEF 14A    12/31/20    1:8.7M                                                            
 2/25/21  Revance Therapeutics, Inc.        10-K       12/31/20  109:12M                                                             
  1/4/21  Schilke Tobin                     4          Officer²    1:4K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    
  1/4/21  Sjuts Dustin S                    4          Officer²    1:4K   Revance Therapeutics, Inc.        Revance Theraps, Inc.    

____________
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	10-K	Annual Report — Form 10-K.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	PRE 14A	Preliminary Proxy Statement — Schedule 14A.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.